Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/1/1991
1.
A Phase I/II Clinical Trial of Brequinar plus Fluorouracil in Patients with Refractory Solid Tumors (Summary Last Modified 08/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 to 80
YALE-HIC-5506
NCI-V91-0051
Last Modified:
6/1/1989
2.
Phase II Chemotherapy with DuP-785 in Patients with Adenocarcinoma of the Pancreas (Summary Last Modified 06/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
EORTC-16871P
Last Modified:
3/1/1989
3.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Breast Cancer (Summary Last Modified 03/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 74
EORTC-16871B
Last Modified:
3/1/1989
4.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Colorectal Cancer (Summary Last Modified 03/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
19 to 74
EORTC-16871C
Last Modified:
4/26/2007
5.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Renal Adenocarcinoma (Summary Last Modified 03/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
EORTC-16871K
Last Modified:
3/1/1989
6.
Phase II Chemotherapy with DuP-785 in Patients with Advanced Malignant Melanoma (Summary Last Modified 03/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
EORTC-16871M
Last Modified:
4/1/1989
7.
Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Refractory Solid Tumors (Summary Last Modified 04/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 80
UNM-2088C
NCI-V89-0021
Last Modified:
5/1/1990
8.
Phase II Chemotherapy with Brequinar Sodium (DuP 785) Administered on a Once-Weekly Schedule in Patients with Advanced Solid Tumors (Summary Last Modified 05/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 80
YALE-HIC-5218
NCI-V89-0234
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute